Lovastatin as an adjuvant to lithium for treating manic phase of bipolar disorder: a 4-week, randomized, double-blind, placebo-controlled clinical trial
about
Lovastatin as an adjuvant to lithium for treating manic phase of bipolar disorder: a 4-week, randomized, double-blind, placebo-controlled clinical trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@ast
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@en
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@nl
type
label
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@ast
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@en
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@nl
prefLabel
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@ast
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@en
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@nl
P2093
P2860
P356
P1476
Lovastatin as an adjuvant to l ...... cebo-controlled clinical trial
@en
P2093
Ali Javadpour
Motahhar OmraniSigaroodi
Sara Shafiee
P2860
P304
P356
10.1155/2014/730505
P577
2014-07-15T00:00:00Z